We are live on ! Find out more

58 hedge funds and large institutions have $21.1M invested in cbdMD in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $827K | Put options by funds: $529K

0.84% less ownership

Funds ownership: 18.42% → 17.59% (-0.84%)

5% less funds holding

Funds holding: 61 → 58 (-3)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

35% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 20

35% less capital inflows, than outflows

Capital inflows: $1.54M | Capital outflows: $2.38M

Holders
58
Holders Change
-3
Holders Change %
-4.92%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
13
Reduced
20
Closed
9
Calls
$827K
Puts
$529K
Net Calls
+$298K
Net Calls Change
+$398K

YCBD Hedge Fund Activity: Q3 2021 in Review

58 of the 5,732 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q3 2021, worth a combined $21.1M — down 31% from $30.4M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of YCBD and 7 opened new positions — a net loss of 2 holders — while 20 trimmed existing stakes and 13 added.

The largest buyer was Ameriprise, adding an estimated $250K. The largest seller was AdvisorShares Investments, cutting an estimated $1.06M.

  • 58 institutional investors held cbdMD (YCBD) as of Q3 2021, down from 61 in Q2 2021.
  • Funds reported $21.1M of cbdMD stock for Q3 2021, down 31% quarter-over-quarter.
  • 7 funds opened new cbdMD positions in Q3 2021 and 9 closed out, a net change of -2 holders.
  • The largest cbdMD buyer in Q3 2021 was Ameriprise, an estimated $250K added.
  • The largest cbdMD seller in Q3 2021 was AdvisorShares Investments, an estimated $1.06M sold.

Based on aggregated 13F filings for Q3 2021.